Your browser is no longer supported. Please, upgrade your browser.
Abiomed, Inc.
IndexS&P 500 P/E76.45 EPS (ttm)4.56 Insider Own1.00% Shs Outstand45.10M Perf Week5.65%
Market Cap15.77B Forward P/E68.76 EPS next Y5.07 Insider Trans-20.56% Shs Float44.14M Perf Month15.21%
Income207.80M PEG4.47 EPS next Q1.13 Inst Own97.30% Short Float4.77% Perf Quarter25.07%
Sales802.90M P/S19.64 EPS this Y-21.00% Inst Trans-0.05% Short Ratio7.05 Perf Half Y18.90%
Book/sh26.22 P/B13.28 EPS next Y12.90% ROA16.70% Target Price326.60 Perf Year90.36%
Cash/sh11.77 P/C29.59 EPS next 5Y17.10% ROE18.90% 52W Range119.01 - 353.49 Perf YTD7.44%
Dividend- P/FCF64.11 EPS past 5Y10.80% ROI17.90% 52W High-1.46% Beta1.42
Dividend %- Quick Ratio6.00 Sales past 5Y29.60% Gross Margin80.80% 52W Low192.68% ATR10.41
Employees1536 Current Ratio6.80 Sales Q/Q2.30% Oper. Margin27.30% RSI (14)77.74 Volatility3.02% 3.07%
OptionableYes Debt/Eq0.00 EPS Q/Q378.60% Profit Margin25.90% Rel Volume1.34 Prev Close347.90
ShortableYes LT Debt/Eq0.00 EarningsJan 28 BMO Payout0.00% Avg Volume298.48K Price348.32
Recom2.30 SMA207.18% SMA5018.72% SMA20032.27% Volume397,022 Change0.12%
Apr-27-20Downgrade SVB Leerink Outperform → Mkt Perform $175
Feb-12-20Downgrade Morgan Stanley Equal-Weight → Underweight $165
Feb-06-20Resumed BTIG Research Neutral
Oct-29-19Downgrade Raymond James Outperform → Mkt Perform
Aug-02-19Downgrade Morgan Stanley Overweight → Equal-Weight $325 → $215
Aug-02-19Downgrade Guggenheim Buy → Neutral
Aug-01-19Downgrade BTIG Research Buy → Neutral
Nov-07-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-02-18Upgrade BTIG Research Neutral → Buy
Jun-22-18Reiterated Piper Jaffray Overweight $360 → $480
Apr-04-18Initiated Goldman Buy $332
Jan-19-18Reiterated Leerink Partners Outperform $200 → $265
Oct-16-17Downgrade BTIG Research Buy → Neutral
Sep-29-17Initiated SunTrust Buy $195
Jun-08-17Resumed William Blair Outperform
Apr-06-17Upgrade Piper Jaffray Neutral → Overweight
Dec-07-16Initiated Guggenheim Buy
Oct-30-15Upgrade Raymond James Mkt Perform → Outperform
Aug-18-15Initiated Sterne Agee CRT Buy $130
Aug-12-15Reiterated The Benchmark Company Buy $96 → $129
Jan-14-21 07:00AM  
Jan-07-21 09:13AM  
Jan-05-21 11:40PM  
Dec-29-20 01:29PM  
Dec-23-20 06:53AM  
Dec-21-20 08:05AM  
Dec-15-20 08:03AM  
Dec-06-20 11:29PM  
Nov-25-20 07:00AM  
Nov-18-20 06:36AM  
Nov-11-20 07:00AM  
Nov-07-20 07:07AM  
Nov-05-20 08:00AM  
Oct-29-20 04:01PM  
Oct-28-20 09:53AM  
Oct-27-20 10:48AM  
Oct-26-20 07:55AM  
Oct-22-20 12:33PM  
Oct-16-20 08:05AM  
Oct-15-20 01:56PM  
Oct-14-20 11:40AM  
Oct-13-20 07:49AM  
Oct-10-20 06:39AM  
Oct-08-20 05:00PM  
Sep-30-20 04:01PM  
Sep-15-20 12:20AM  
Sep-14-20 07:00AM  
Sep-08-20 07:00AM  
Sep-05-20 11:31AM  
Aug-31-20 08:00AM  
Aug-27-20 07:24AM  
Aug-24-20 12:40PM  
Aug-18-20 12:45PM  
Aug-06-20 09:26AM  
Aug-04-20 08:50AM  
Jul-31-20 08:02AM  
Jul-30-20 08:00AM  
Jul-22-20 11:40AM  
Jul-20-20 08:19AM  
Jul-16-20 07:00AM  
Jul-12-20 07:38PM  
Jul-02-20 09:00AM  
Jul-01-20 07:00AM  
Jun-17-20 10:29AM  
Jun-16-20 07:00AM  
Jun-15-20 07:00AM  
Jun-12-20 11:40AM  
Jun-10-20 06:59PM  
Jun-08-20 02:50PM  
Jun-05-20 09:41AM  
Jun-03-20 04:30PM  
Jun-01-20 02:05PM  
May-30-20 11:31AM  
May-27-20 04:30PM  
May-20-20 07:00AM  
May-19-20 09:32AM  
May-15-20 10:38AM  
May-11-20 02:39PM  
May-05-20 10:09AM  
May-03-20 08:06AM  
May-01-20 06:25AM  
Apr-30-20 03:44PM  
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenfield Andrew JVP, Chief Commercial OfficerDec 29Sale321.005,0001,605,00026,930Dec 31 04:03 PM
Greenfield Andrew JVP, Chief Commercial OfficerDec 22Sale296.671,682498,99731,930Dec 23 04:04 PM
Greenfield Andrew JVP, Chief Commercial OfficerDec 21Sale295.635,4741,618,27933,612Dec 23 04:04 PM
SUTTER MARTIN PDirectorNov 18Sale268.34750201,255184,010Nov 19 06:16 PM
SUTTER MARTIN PDirectorNov 17Sale269.53750202,148184,760Nov 19 06:16 PM
MINOGUE MICHAEL RChairman, President, CEOAug 21Option Exercise22.4440,000897,600250,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 21Sale306.3340,00012,253,177210,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 20Option Exercise22.4460,0001,346,400270,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 20Sale310.9860,00018,658,744210,746Aug 24 05:45 PM
SUTTER MARTIN PDirectorAug 19Sale312.38750234,285186,260Aug 20 04:40 PM
SUTTER MARTIN PDirectorAug 18Sale311.99750233,993187,760Aug 20 04:40 PM
THOMAS PAULDirectorAug 10Sale303.412,000606,8206,530Aug 11 04:07 PM
PUHY DOROTHY EDirectorJul 15Sale275.007,5002,062,5007,652Jul 17 04:02 PM
PUHY DOROTHY EDirectorJun 05Sale250.007,5001,875,00015,152Jun 09 04:04 PM
SUTTER MARTIN PDirectorMay 04Option Exercise9.9912,000119,880200,939May 06 04:02 PM
SUTTER MARTIN PDirectorMay 04Sale180.5812,0002,166,928188,939May 06 04:02 PM
THOMAS PAULDirectorMar 02Sale151.782,000303,5618,920Mar 04 04:23 PM
THOMAS PAULDirectorFeb 10Sale181.132,000362,25010,920Feb 12 05:14 PM